Cite
MLA Citation
David T. Rubin et al.. “Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis.” Alimentary pharmacology & therapeutics, vol. 55, no. 3, 2022, pp. 302–310. http://access.bl.uk/ark:/81055/vdc_100148850248.0x000048